Abstract | BACKGROUND: METHODS: RESULTS: Using a HABP-19 molecular imaging probe, we have shown that it is possible to selectively image hydroxyapatite calcifications in osteotropic cancers ex vivo and in human SaOS-2 osteosarcoma cells in vitro. CONCLUSION:
Hydroxyapatite calcifications were selectively detected in osteotropic tissues ex vivo and in the early stage of the calcification process of SaOS-2 human osteosarcoma in vitro using our HABP-19 molecular imaging probe. This new target-selective molecular imaging probe makes it possible to study the earliest events associated with hydroxyapatite deposition in various osteotropic cancers at the cellular and molecular levels. GENERAL SIGNIFICANCE: It potentially could be used to diagnose and treat osteotropic cancer or to anchor therapeutic agents directing the local distribution of desired therapy at calcified sites.
|
Authors | Jae Sam Lee, Ching-Hsuan Tung |
Journal | Biochimica et biophysica acta
(Biochim Biophys Acta)
Vol. 1830
Issue 10
Pg. 4621-7
(Oct 2013)
ISSN: 0006-3002 [Print] Netherlands |
PMID | 23688398
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Osteocalcin
- Durapatite
- Fluorescein-5-isothiocyanate
|
Topics |
- Bone Neoplasms
(diagnosis, metabolism)
- Cell Line, Tumor
- Durapatite
(metabolism)
- Fluorescein-5-isothiocyanate
- Humans
- Molecular Mimicry
- Osteocalcin
(metabolism)
- Osteosarcoma
(diagnosis, metabolism)
- Tissue Array Analysis
|